Article Text

Download PDFPDF

Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein
  1. L Šenolt,
  2. M Braun,
  3. M Olejárová,
  4. Š Forejtová,
  5. J Gatterová,
  6. K Pavelka
  1. Institute of Rheumatology, Prague and Clinic of Rheumatology, Charles University, 1st Medical School, Prague, Czech Republic
  1. Correspondence to:
    Professor K Pavelka
    Institute of Rheumatology, Na Slupi 4, 12850 Prague 2, Czech Republic;


Background: Pentosidine, an advanced glycation end product, increasingly accumulates in articular cartilage with age, and contributes to the pathogenesis of osteoarthritis (OA). Increased pentosidine concentrations are associated with inflammatory disorders—for example, rheumatoid arthritis.

Objective: To compare pentosidine serum concentrations in patients with knee OA and in healthy volunteers and to determine a relationship between pentosidine and cartilage oligomeric matrix protein (COMP)—a marker of articular cartilage destruction.

Methods: Paired serum and synovial fluid samples were obtained by arthrocentesis from 38 patients with knee OA and from 38 healthy volunteers. Pentosidine concentration was measured by reverse phase high performance liquid chromatography with fluorescent detection and COMP was determined by sandwich ELISA.

Results: Significantly increased serum pentosidine (p<0.01) and COMP (p<0.05) levels were detected in the patients with OA compared with the control group. Serum pentosidine correlated significantly with synovial fluid pentosidine (p<0.001). Pentosidine in synovial fluid (p<0.05) and in serum (p<0.05) correlated significantly with synovial fluid COMP. Pentosidine and COMP concentrations did not correlate significantly with the radiological stage of the disease.

Conclusion: Increased pentosidine serum concentration in patients with OA and its correlation with the cartilage destruction marker COMP in synovial fluid suggests that pentosidine may be important in OA pathology and is a new potential OA marker.

  • AGE, advanced glycation end product(s)
  • ANOVA, analysis of variance
  • COMP, cartilage oligomeric matrix protein
  • OA, osteoarthritis
  • RA, rheumatoid arthritis
  • advanced glycation end products
  • pentosidine
  • cartilage oligomeric matrix protein
  • osteoarthritis
  • pentosidine

Statistics from

Supplementary materials

Related Data


Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.